(VIANEWS) – Shares of Xenetic Biosciences (NASDAQ: XBIO) fell by a staggering 28.04% in 30 days from $1.07 to $0.77 at 16:26 EST on Wednesday, after five sequential sessions in a row of gains. NASDAQ is sliding 4.56% to $11,438.30, following the last session’s upward trend.
Xenetic Biosciences’s last close was $0.78, 86.29% under its 52-week high of $5.68.
Today’s last reported volume for Xenetic Biosciences is 48539 which is 77.26% below its average volume of 213468.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the present quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a positive 5.50%, a negative 2.00%, and a positive 3.78%, respectively.
Xenetic Biosciences’s highest amplitude of average volatility was 5.50% (last week), 4.68% (last month), and 3.78% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.77 at 16:26 EST, way below its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way under its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences (XBIO).